Orange City – potency remedy | Buy in Ukraine with delivery
There are no products to list.
ORANGE CITY is a modern combination-action medicinal drug belonging to the pharmacotherapeutic group of agents for supporting the functional state of the cardiovascular system and normalizing metabolic processes in the myocardium. The product is manufactured in the form of hard gelatin capsules with prolonged release of active substances, which provides a uniform therapeutic effect throughout the day. The manufacturer of ORANGE CITY is the pharmaceutical company Orange City, which specializes in the development of innovative cardiological and metabolic drugs with proven bioavailability. Each capsule contains a carefully selected complex of active components that act synergistically to improve cellular energy metabolism and protect the vascular wall. The drug is dispensed by prescription and is intended for a course of treatment under the supervision of a specialist.
The pharmacological action of ORANGE CITY is determined by its ability to influence key links in the pathogenesis of ischemic and metabolic disorders in tissues. The drug belongs to the group of metabolitotropic agents that not only eliminate symptoms, but also restore the normal functioning of cellular structures. A special feature of ORANGE CITY is the combination of antioxidant, antihypoxic, and cytoprotective activity, which allows its use both as part of complex therapy and as monotherapy in the initial stages of disorders. Thanks to the original microencapsulation technology, active substances are released gradually, which reduces the risk of adverse reactions and prolongs the duration of action. Clinical studies have confirmed the high efficacy of the drug with course application lasting from four to eight weeks.
ORANGE CITY stands out among analogues due to its balanced composition, which takes into account modern concepts of the mechanisms of oxidative stress and endothelial dysfunction development. The drug has passed a full cycle of preclinical and clinical trials, confirming its safety and therapeutic efficacy in patients of various age groups. The manufacturer Orange City guarantees the compliance of each batch of the drug with international GMP quality standards, ensuring the stability of pharmacological properties. The drug is registered in Ukraine and approved for medical use in accordance with current legislation. Before starting to take ORANGE CITY, it is mandatory to consult a physician to determine the appropriateness of use and individual selection of dosage.
ORANGE CITY is prescribed to patients with chronic ischemic heart disease to reduce the frequency of angina attacks and increase exercise tolerance. The drug contributes to improving the energy supply of cardiomyocytes under conditions of insufficient oxygen supply, which helps reduce the severity of pain syndrome and prevent the development of acute coronary events. Due to its antihypoxic action, ORANGE CITY helps heart muscle cells use available oxygen more efficiently and switch metabolism to more economical energy production pathways. This is especially important for elderly patients whose compensatory reserves of the body are significantly reduced.
The second important area of application of ORANGE CITY is myocardial metabolic disorders, in particular dystrophic changes in the heart muscle against the background of diabetes mellitus, thyrotoxicosis, or chronic intoxications. The drug normalizes the oxidation processes of fatty acids and glucose, restoring the balance between the myocardium's demand for oxygen and its delivery. ORANGE CITY is also prescribed during the rehabilitation period after myocardial infarction to accelerate the recovery of functional cardiac activity. Clinical experience shows that course application of the drug helps reduce the area of ischemic lesion and improve myocardial contractility.
ORANGE CITY is effective in vegetative-vascular dystonia and neurocirculatory asthenia, accompanied by cardialgia, a feeling of disruptions in heart activity, and reduced work capacity. The drug gently stabilizes the autonomic regulation of cardiac activity, eliminates feelings of anxiety, and improves the overall well-being of patients. ORANGE CITY is also used as part of complex therapy for arterial hypertension to protect the myocardium from hypertrophic changes and improve endothelial function of blood vessels. In sports medicine, the drug is used to increase endurance and accelerate recovery after intense physical exertion; however, such use should be agreed upon with a doctor.
The main active substances of ORANGE CITY are ubidecarenone (coenzyme Q10), L-carnitine tartrate, and magnesium orotate, which together form a powerful metabolic complex. Ubidecarenone is a key cofactor of the mitochondrial respiratory chain, ensuring the synthesis of adenosine triphosphate — the main source of energy for cells. L-carnitine performs a transport function, carrying long-chain fatty acids through the mitochondrial membrane for their subsequent oxidation and energy production. Magnesium orotate stabilizes cell membranes, participates in the regulation of vascular tone, and prevents excessive accumulation of calcium in cells, which reduces the risk of arrhythmias.
Excipients of ORANGE CITY include microcrystalline cellulose, corn starch, magnesium stearate, and silicon dioxide, which ensure the stability of the capsule shape and uniform distribution of active substances. The capsule shell is made of hypromellose — a plant-based analogue of gelatin, making the product suitable for patients following a vegetarian diet. Prolonged-release technology involves the use of special polymer matrices that gradually dissolve in the gastrointestinal tract. This allows maintaining the therapeutic concentration of active substances in the blood for twelve hours after a single intake.
The mechanism of action of ORANGE CITY is realized through the activation of mitochondrial oxidation and reduction of the intensity of free radical processes in cells. Coenzyme Q10 neutralizes reactive oxygen species, protecting the lipid bilayer of membranes from lipid peroxidation and preserving the integrity of cardiomyocytes. L-carnitine facilitates the switch of metabolism from glycolysis to more efficient oxidation of fatty acids, which decreases lactate accumulation and prevents the development of intracellular acidosis. Magnesium orotate additionally stimulates the synthesis of nucleic acids and proteins necessary for the repair of damaged cellular structures and recovery of functional myocardial activity.
The standard therapeutic dose of ORANGE CITY for adult patients is one capsule twice a day — in the morning and evening during or immediately after meals. The capsule should be swallowed whole, without chewing or crushing, taken with a sufficient amount of room-temperature water. In severe myocardial metabolic disorders, a physician may increase the daily dose to three capsules divided into three intakes; however, such a decision is made individually after evaluating the clinical picture. The duration of course application of ORANGE CITY is usually from four to eight weeks, after which a follow-up examination is performed to evaluate the efficacy of the therapy.
For elderly patients, dose adjustment of ORANGE CITY is usually not required, as the drug is well tolerated and does not accumulate in the body. However, in the presence of severe liver or kidney function impairment, it is recommended to start therapy with the minimum effective dose — one capsule per day — with subsequent titration under medical supervision. Patients with severe chronic renal failure are prescribed ORANGE CITY with caution, as part of the metabolites is excreted by the kidneys. The duration of therapy may be extended up to three months by a doctor's decision if the clinical response to treatment is insufficient.
If a regular dose of ORANGE CITY is missed, a double dose should not be taken to compensate, as this may increase the risk of adverse reactions. Instead, intake should be continued according to the usual scheme, maintaining an interval of at least eight hours between doses. Children and adolescents under eighteen years of age are prescribed ORANGE CITY only in exceptional cases for strict indications and under close medical supervision. Unauthorized dose increases or extension of the treatment course without consulting a specialist are unacceptable and can lead to undesirable health consequences.
ORANGE CITY should be taken during or immediately after meals, as the presence of food in the stomach improves the absorption of lipid-soluble components of the product, particularly coenzyme Q10. It is recommended to wash down the capsule with half a glass of still water, avoiding hot drinks that can prematurely destroy the capsule shell. Optimal intake occurs at the same time every day, which helps establish a stable therapeutic concentration of active substances in the blood. For patients who have difficulty swallowing, it is permissible to open the capsule and mix its contents with a small amount of soft food, but this method of intake should be pre-approved by a physician.
During the course application of ORANGE CITY, it is important to adhere to regularity of administration and not interrupt treatment without consulting a specialist, even if health has significantly improved. The therapeutic effect of the drug develops gradually, so the first positive changes may become noticeable only after two to three weeks of regular intake. Patients are recommended to keep a self-monitoring diary, recording the frequency and intensity of symptoms, which will allow the doctor to objectively evaluate the efficacy of therapy. If any unusual reactions occur, you should immediately consult a doctor for dosage adjustment or drug replacement.
ORANGE CITY should not be combined with other metabolic agents without prior consultation with a doctor, as duplication of active components and exceeding the safe daily dose may occur. The drug is compatible with most cardiac medications; however, the interval between taking ORANGE CITY and other medicines should be at least two hours to avoid potential interaction. Patients with gastrointestinal absorption disorders may require dosage adjustment or selection of an alternative drug form. It is important to remember that individual bodily reaction to any medication may vary, making self-treatment unacceptable.
ORANGE CITY is generally well tolerated by patients; however, in some cases, adverse reactions from the gastrointestinal tract may occur, such as nausea, a feeling of heaviness in the epigastrium, flatulence, or diarrhea. These symptoms most often appear at the start of therapy and disappear independently within a few days as the body adapts to the drug. To reduce the severity of dyspeptic events, taking ORANGE CITY after meals with a sufficient amount of water is recommended. In rare cases, the development of allergic reactions in the form of skin rash, itching, or hives is possible, which requires discontinuation of the drug and medical consultation.
From the nervous system, sensitive patients may experience headaches, dizziness, or sleep disturbances, especially when taking the drug in the evening. To avoid insomnia, taking the second dose of ORANGE CITY no later than four hours before bedtime is recommended. In isolated cases, a feeling of palpitations or a slight increase in blood pressure at the beginning of therapy has been reported, which usually passes without additional intervention. Patients with a labile nervous system should start treatment with the minimum dose to assess individual tolerance to the drug.
Immediate medical attention is required for symptoms such as severe abdominal pain, vomiting, yellowish discoloration of the skin or sclera, a significant drop in blood pressure, as well as any signs of an anaphylactic reaction — difficulty breathing, swelling of the face or larynx. These manifestations may indicate individual intolerance to the drug components and require urgent medical care. Overall, the frequency of side effects with ORANGE CITY is low and does not exceed placebo rates in clinical trials. Subject to recommended doses and administration regimen, the risk of developing adverse reactions is minimal.
ORANGE CITY has clearly defined absolute contraindications, in the presence of which the use of the drug is strictly forbidden. These include increased individual sensitivity to any of the components of the drug, severe liver function impairment with manifestations of hepatic failure, as well as terminal stage renal failure. The drug is not prescribed to patients with acute cerebrovascular accident, acute myocardial infarction within the first seven days from the onset of the disease, and pronounced arterial hypotension. ORANGE CITY is also contraindicated in hereditary fructose intolerance, as the capsule shell includes cellulose derivatives that are metabolized with the participation of specific enzymes.
Relative contraindications include conditions under which the use of ORANGE CITY is possible only under close medical supervision after assessing the benefit-to-risk ratio. This applies to patients with gastric and duodenal ulcer disease in the acute stage, cholelithiasis, chronic pancreatitis, and cardiac arrhythmias of unknown origin. The drug is prescribed with caution to patients with severe arterial hypertension, as magnesium orotate can potentiate the effect of antihypertensive agents. If any unusual symptoms appear during therapy, you must immediately inform your doctor to decide on the appropriateness of continuing treatment.
For pregnant women, ORANGE CITY is prescribed only in cases where the expected benefit to the mother outweighs the potential risk to the fetus, as adequate controlled safety studies in this category of patients have not been conducted. During breastfeeding, the use of the drug is not recommended, and if treatment is necessary, the issue of temporary cessation of breastfeeding should be resolved. Children and adolescents under eighteen years of age are not prescribed ORANGE CITY due to the lack of a sufficient evidence base regarding efficacy and safety in this age group. Elderly patients may use the drug in standard doses provided there are no severe concomitant diseases.
ORANGE CITY can enter into drug interactions with certain groups of medications, requiring caution with simultaneous use. In particular, magnesium orotate can enhance the effects of peripheral muscle relaxants and reduce the absorption of tetracycline antibiotics; therefore, the interval between taking these agents must be at least three hours. Simultaneous use of ORANGE CITY with indirect anticoagulants requires regular monitoring of blood clotting parameters, as coenzyme Q10 is structurally similar to vitamin K and can reduce the efficacy of warfarin. The drug is not recommended to be combined with other products containing coenzyme Q10 or L-carnitine to avoid overdose.
Consumption of alcohol during ORANGE CITY therapy is strictly not recommended, as ethanol negatively affects metabolic processes in the myocardium and can negate the therapeutic effect of the drug. Alcohol increases oxidative stress and contributes to the depletion of coenzyme Q10 reserves in tissues, which contradicts the main goal of treatment. Furthermore, combining ORANGE CITY with alcohol increases the load on the liver and raises the risk of adverse gastrointestinal reactions. The drug does not affect psychomotor reaction speed and the ability to drive vehicles; however, if dizziness or drowsiness occurs, one should refrain from driving until the cause of these symptoms is clarified.
ORANGE CITY is available for purchase in pharmacy chains throughout Ukraine, as well as in specialized online pharmacies that deliver medicinal products in accordance with current legislation. The drug is dispensed by prescription; therefore, to purchase it, you must have an appropriate prescription properly filled out. The cost of ORANGE CITY may vary depending on the region and the pricing policy of a specific pharmacy chain, so comparing prices in several sources before buying is recommended. The availability of the drug in a specific pharmacy can be checked using online medication booking services that provide up-to-date information on stock balances.
ORANGE CITY should be stored in a dry place protected from light at a temperature not exceeding twenty-five degrees Celsius, out of the reach of children. The shelf life of the drug is three years from the manufacturing date indicated on the package, after which use is forbidden. When ordering online, it is important to ensure that the pharmacy holds a license for retail trade in medicinal products and complies with drug storage conditions during transportation. Before starting the use of ORANGE CITY, it is necessary to read the instructions carefully and consult a doctor regarding the appropriateness and safety of therapy in a specific clinical case.
Self-medication can be dangerous to your health. Consult a doctor before using this medication..